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Purpose of review
For over a decade, the importance of zinc in the treatment of acute diarrhea has been
recognized. More recently, the mechanisms of action of zinc are becoming clearer.
This review is focused on the new evidence on the mechanisms of action of zinc in acute
diarrhea.
Recent findings
The vast majority of data derive from in-vitro studies using intestinal cell lines or from
animal model. The positive action by zinc in acute diarrhea derives from a regulation of
intestinal fluid transport, mucosal integrity, immunity, gene expression, and oxidative
stress. A complex homeostatic network is also able to regulate zinc status at cellular and
extracellular level.
Summary
All these data support the use of zinc in the treatment of acute diarrhea, but further
clinical studies are needed to explore the selective effects of zinc against specific
pathogens responsible for diarrhea.
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Diarrhea causes almost 1.3 million deaths annually in
children less than 5 years of age, mainly in the poorest
regions of the world. Reduction in this mortality burden is
crucial to achieve the UN’s Millennium Development
Goal 4 to decrease the child mortality rate by two-thirds
between 1990 and 2015 [1]. Recent evidence has
demonstrated that zinc supplementation has a consider-
able beneficial effect on the clinical course of acute
diarrhea, and more recently, the mechanisms of action
of zinc are becoming clearer [2]. As reported in a recent
systemic review, zinc supplementation reduced the mean
duration of acute diarrhea by approximately 20% and
persistent diarrhea by 15–30% [3]. Recently, another
systemic review of the effects of zinc for diarrhea treat-
ment was designed to meet the needs of the Lives Saved
Tool (LiST). In LiST, increases in coverage of an inter-
vention result in a reduction of one or more causes of
mortality. The mentioned review was designed to
develop estimates of the effect of an intervention in
reducing death due to diarrhea and it reported that zinc
for the treatment of diarrhea will reduce diarrhea
mortality by 23%. In addition, zinc has been shown to
decrease diarrhea prevalence in both 24-h and 2-week
recall survey [4]. Introduction of zinc to community0267-1379  2010 Wolters Kluwer Health | Lippincott Williams & Wilkinsprograms resulted in increased use of oral rehydration
solution (ORS), decreased use of unnecessary antibiotics,
and a reduced need for medical visits for acute diarrhea
[5]. Zinc is now included in the WHO essential medicine
list for diarrhea treatment, and in the 2008 Copenhagen
Consensus, a group of leading global economists ranked
zinc supplementation as the most effective intervention
for advancing human development [6]. Zinc is now
widely used in the treatment of acute diarrhea in devel-
oping countries where it is responsible for saving more
than 400 000 lives a year [7]. Moreover, a universal zinc-
containing super ORS has been proposed by various
authors [1,8]. This review is focused on the new evi-
dence on the mechanisms of action of zinc in acute
diarrhea.Toward a better definition of the mechanisms
of zinc in acute diarrhea
Zinc is one of the most important trace elements for
human health. It serves over 300 biological functions and
elicits effects on multiple systems, including the gastro-
intestinal tract [9]. Zinc is not stored in the body, so its
level is determined by the balance of dietary intake,
absorption, and losses. A zinc deficiency state may exist
in children with acute diarrhea as a result of intestinalDOI:10.1097/MOG.0b013e32833fd48a
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bility to diarrhea [10]. The positive action by zinc in acute
diarrhea derives from several possible mechanisms: first,
zinc regulates intestinal fluid transport and mucosal
integrity; second, zinc plays a substantive role in immu-
nity; third, zinc can modify expression of genes encoding
several zinc-dependent enzymes, such as metallopro-
teases, cytokines and uroguanylin; fourth, zinc may
modulate oxidative stress [11,12,13]; and lastly, zinc
is able to resist its potential loss in diarrhea. The intestine
is the first tissue confronted with zinc. Sufficient absorp-
tion of zinc from the small intestine is essential for body
health, but high levels of zinc are deleterious. Thus,
maintaining an appropriate zinc level is crucial. Zinc
homeostasis is coordinated via regulation by proteins
involved in uptake, excretion, and intracellular storage
or trafficking. These proteins are metallothioneins and
transmembrane transporters, which include zinc-
regulated transporter (ZRT) iron-regulated transporter
(RT)-like protein (ZIP) and cation diffusion facilitator
(CDF) families. Metallothioneins belong to a family of
low molecular weight, cysteine-rich intracellular proteins
that bind zinc, and their biological roles include the
detoxification of harmful metals and the homeostasis of
essential metals. The ZIP family plays prominent roles in
zinc uptake and transport into the cytoplasm. ZIP trans-
porters have also been found to mobilize stored zinc by
transporting the metal from an intracellular compartment
into the cytoplasm. The CDF family transports zinc in
the direction opposite to that of the ZIP proteins, pro-
moting zinc efflux or compartmentalization by pumping
zinc from the cytoplasm out of the cell or into the lumen
of an organelle. Zinc transporter proteins (ZnT) are other
members of the CDF families. ZnT1, a ubiquitous ZnT
located in the plasma membrane, transports zinc out of
cells. In addition, divalent metal transporter (DMT1) is
located in the apical membrane of enterocytes and takes
iron into enterocytes. It is predominantly an iron trans-
porter, with lower affinity for other metals such as zinc.
Some data indicate that zinc transport is upregulated by
DMT1 based on protein levels and mRNA expression
[14]. In addition, during the stage of acute inflammation,
monocytes secrete proinflammatory chemokines that
stimulate ZIP4 in the hepatocytes, thereby arresting
and storing zinc by fusing it with metallothioneins. How-
ever, circulating zinc ions also have the ability to decrease
hyperfunctional monocytes and, thus, reduce a precipi-
tous fall of zinc ions in circulation [15].Effects of zinc on intestinal transepithelial ion
transport
Zinc induces ion absorption in enterocytes in basal con-
ditions. Zinc addition to the mucosal side of a monolayer
of human enterocyte cell line (Caco-2 cell) mounted
in Ussing chambers induced a decrease in short-circuitcurrent (Isc), indicating ion absorption with a maximal
effect at 25 min. Zinc addition to the basolateral side of
enterocytes induced a decrease in Isc entirely similar to
that observed with mucosal addition, although the mag-
nitude of the response was slightly reduced compared to
that observed with mucosal addition [16]. These results
indicate that zinc exerts a direct proabsorptive effect on
intestinal transepithelial ion transport.
A number of organisms cause diarrhea by producing and
secreting enterotoxins that affect the absorptive and/or
secretory processes of the enterocyte without causing
considerable acute inflammation or mucosal destruction.
Some enterotoxins trigger signaling molecules such as
cyclic AMP (cAMP) or cyclic GMP (cGMP), which, in
turn, activate apical Cl channels, leading to an increase
in secretion of Cl and consequently of water [16,
17,18]. Using an in-vitro model, we have demonstrated
that zinc prevents active ion secretion induced by cholera
toxin by directly inhibiting the rise in intracellular cAMP
concentration, but that it does not affect Escherichia coli
heat-stable enterotoxin-induced and cGMP-mediated
ion secretion [16]. These findings suggest that zinc exerts
a selective effect against intestinal pathogens (Fig. 1).
Several toxins, including Ciguatera fish toxin, Clostridium
difficile toxin, Cryptosporidium parvum toxin, Rotavirus
enterotoxin (the nonstructural protein 4, NSP4), Helico-
bacter pylori vacuolating toxin, and Vibrio parahaemolyticus
enterotoxin induce a direct secretory effect in the enter-
ocyte modifying intracellular Ca2þ [11,17,18]. We
have reported that the transactivator factor peptide
(Tat) produced by HIV-1, functioning as an enterotoxin,
induces ion secretion by a Ca2þ-mediated mechanism.
Subsequently, we demonstrated that the preincubation
of human enterocytes with zinc resulted in almost total
inhibition of the Tat-induced ion secretion interacting
directly with a specific mechanism of HIV-1-related
diarrhea. These data, providing an explanation for the
observed reduction of diarrhea in patients with HIV
infection during zinc supplementation, suggest that zinc
could act also in Ca2þ-mediated diarrhea [19]. These
effects are particularly interesting for childhood diarrhea.
In fact, Rotavirus, the major agent of acute diarrhea in
infancy, stimulates Cl secretion through a phospho-
lipase C-dependent Ca2þ signaling pathway induced
by the NSP4 [20].
The importance of nitric oxide as a second messenger
involved in intestinal ion secretion has become fully
recognized only recently. The pathogenic effects exerted
by nitric oxide are strictly concentration-dependent and
associated with an increased nitric oxide production
triggered by the activity of inducible nitric oxide synthase
isoform (iNOS), an enzyme involved in selected infec-
tious and noninfectious diarrheal diseases. Zinc is an
established nitric oxide scavenger, and these data suggest
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Figure 1 Main intracellular pathways of intestinal ion secretion modulated by zinc
In-vitro evidence suggests that zinc is able to inhibit three out of the four main intracellular pathways of intestinal ion secretion: cyclic adenosine
monophosphate (cAMP), calcium (Ca2þ), and nitric oxide. But it is unable to affect cyclic guanosine monophosphate (cGMP)-induced ion secretion. In
the figure are also reported the main agonists of these pathways.that zinc could be effective in nitric oxide-induced ion
secretion. We showed that zinc significantly inhibits
intestinal Cl secretion induced by interferon-g, a well
established agonist of this mechanism, and this was
associated with a decrease in nitric oxide production
by the enterocytes [11]. These results confirm previous
observations, obtained in in-vivo animal models, showing
that zinc is able to inhibit lipopolysaccharides and IL-1-
induced diarrhea through a reduction in nitric oxide
production and by removing chemically nitric oxide
generated in the gut. Previous data have suggested that
zinc and nitric oxide play an active regulatory role in
intestinal ion transport. A low nitric oxide concentration,
sustained by constitutive nitric oxide synthase, maintains
the physiological intestinal ion pro-absorptive tone. On
the contrary, an excess of nitric oxide production stimu-
lated by pro-inflammatory cytokines or microbial toxins
induces intestinal fluid secretion through an upregulation
of iNOS. This mechanism may be activated in intestinal
infections and inflammation and an overexpression of
iNOS gene have been demonstrated in zinc-deficient
animal model. The results of our study suggest that zinc
is part of this network in the enterocyte. The number of
intestinal pathogens that utilize nitric oxide to induce
diarrhea is limited, but not negligible. Shigella entero-
toxin 1 exerts an irreversible, dose-dependent entero-
toxic effect mediated by an increased nitric oxide
intestinal concentration that is partially blocked by iNOSinhibitors. However, high nitric oxide production has
been shown to contribute to diarrhea by acting as a
secretagogue, in particular in inflammatory diarrhea. In
light of this fact, the effects of zinc on the nitric oxide
pathway open new perspectives in the treatment of
intestinal inflammatory diseases.Effects of zinc on intestinal mucosa integrity,
cell growth, and differentiation
Previous studies have shown that zinc plays a key role in
the maintenance of membrane barrier function and in
controlling inflammatory reactions by showing that the
depletion of zinc causes phosphorylation-mediated dis-
ruption of junctional complexes and cytoskeleton dis-
organization, thus promoting the migration of neutrophils
[21,22]. The presence of high zinc concentration
(>200mmol/l) or zinc chelating agent in cells could
induce apoptosis. High or low (<10mmol/l) zinc concen-
tration inhibits enterocyte proliferation [15]. Remark-
ably, these doses correspond to that observed in ion
transport experiments [11], suggesting a possible link
between transepithelial ion transport and cell growth
processes. Cell cycle progression involves the activation
of the intracellular MAP kinase cascade [23] that leads to
DNA synthesis in the nuclei. We investigated whether
the extracellular signal-regulated kinase (ERK) pathway,
a member of the MAP kinase family, was involved in the
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Table 1 Effects of zinc deficiency on immune system
T-cell subpopulation Th1 cytokines Th2 cytokines NK cell Others
CD4þ to CD8þ ratio
decreased
IL-2 production and
IL-2 mRNA
decreased
No change in IL-4,
IL-6, and IL-10
Binding of NF-kB to DNA and
its translocation from cytosol
to nucleus decreased
Thymulin activity decreased
CD4þ CD45RAþ to
CD4þ CD45ROþ
ratio decreased
IL-2R-a and IL-2-b
production and
mRNAs decreased
IkB phosphorylation decreased,
accounting for decreased
activation of NF-kB
Increase in the levels of
TNF-a, IL-1-b, and
cytokines and mRNA
IFN-g decreased CD8þ CD73þ decreased Increased lipid peroxidation
by nitric oxide
Increased NF-kB-DNA binding
in LPS-stimulated cells
Decreased production and
mRNA of A-20
IFN, interferon; IL, interleukin; NF-kB, nuclear factor-kB; NK, natural killer.zinc-induced cell response. Upregulation of ERK1/2 was
induced by zinc in undifferentiated Caco-2 cells. In
addition, cell differentiation is an important process at
intestinal level. Genetic programming and selected fac-
tors play a role in intestinal differentiation in modulating
brush border disaccharidase expression. Sucrase and
lactase are markers of enterocyte differentiation and
increase during cell migration from the crypt to villus
tip. Under zinc stimulation, both sucrase and lactase
activities were significantly increased, suggesting that
zinc induces enterocyte differentiation (personal obser-
vation).Effects of zinc on intestinal defense
mechanisms
The intestinal defense mechanisms against pathogens
determining diarrhea are numerous; among these, the
most important are the epithelial barrier and the cellular
and humoral constituents of innate and acquired immu-
nity. These parts interact in complex networks protecting
against acute diarrhea and zinc has been shown to be a
crucial player in immunonutrition [24]. Several recent
reviews have documented the immune-related functions
of zinc [12,13,25].
Both primary and secondary antibody responses have
been reported to be depressed in zinc-deficient animal
models. Zinc is considered as a key player in innate and
acquired immunity and zinc homeostasis influences the
development and function of immune cells, particularly
T cells. In humans even a mild deficiency of zinc may be
accompanied by an imbalance of Th1 and Th2 cells,
decreased recruitment of T-naive cells, decreased per-
centage of T cytolytic cells, decreased natural killer (NK)
cell lytic activity, and decreased serum thymulin activity
(see Table 1). Studies on cell culture models showed that
the activation of many zinc-dependent enzymes and
transcription factors is adversely affected due to zinc
deficiency. In HUT-78 [T helper 0 (Th0) cell line], it
has been shown that a decrease in gene expression of
interleukin-2 (IL-2) and IL-2 receptor-a (IL-2R-a) were
due to decreased activation of nuclear factor-kB (NF-kB)
in zinc-deficient cells. Decreased NF-kB activation inHUT-78 due to zinc deficiency was due to decreased
binding of NF-kB to DNA, decreased level of NF-kB
p105 (the precursor of NF-kB p50) mRNA, decreased kB
inhibitory protein (IkB) phosphorylation, and decreased
Ikk. These effects of zinc were cell-specific. In HL-60
cells (promyelocytic leukemia cell line), zinc enhances
the upregulation of A20 mRNA, which, via TRAF path-
way, decreases NF-kB activation, leading to decreased
gene expression and generation of tumor necrosis factor-
a (TNF-a), IL-1-b, and IL-8.
The ability of zinc to function as an antioxidant and to
stabilize membranes suggests that it has a role in the
prevention of free radical-induced injury during inflam-
matory processes. Together O2, H2O2, and OH are
known as reactive oxygen species (ROS), and these are
produced continuously in vivo under aerobic conditions.
The NADPH oxidase is a group of plasma membrane-
associated enzymes, which catalyze the production of
O2
– from oxygen by using NADPH as the electron donor.
Zinc is an inhibitor of this enzyme. The dismutation of
O2
– to H2O2 is catalyzed by an enzyme super oxide
dismutase (SOD), which contains both copper and zinc.
Zinc is known to induce the production of metallothio-
neins and is an excellent scavenger of OH [14]. Iron and
copper ions catalyze the production of OH from H2O2.
Zinc is known to compete with both iron and copper for
binding to cell membrane, thus decreasing the pro-
duction of OH [14].Conclusion
Zinc is a multipotent agent at intestinal level: it modu-
lates ion transport, stimulates enterocyte growth and
differentiation, reduces intestinal permeability, and posi-
tively regulates oxidative stress and inflammation. Few
other substances exert such a variety of beneficial effects
in the intestine. As an adjunct to ORS, zinc has the
potential to improve the management of acute diarrhea,
determined by different mechanisms, at affordable costs.
Recently, main in-vitro advances have been obtained in
our knowledge on cellular mechanism elicited by zinc
that could be potentially useful to support its use in the
treatment of acute diarrhea. Further clinical studies are
12 Gastrointestinal infectionsneeded to explore the selective effects of zinc against
specific pathogens responsible for diarrhea.References and recommended reading
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